Avanos Medical, Inc.
AVNS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,400 | -$76,800 | $6,600 | -$397,300 |
| Dep. & Amort. | $9,400 | $10,000 | $9,600 | $11,100 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4,100 | $3,800 | $3,800 |
| Change in WC | -$2,900 | -$6,800 | $5,400 | $45,000 |
| Other Non-Cash | $8,900 | $76,300 | $300 | $395,300 |
| Operating Cash Flow | $14,000 | $6,800 | $25,700 | $57,900 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,000 | -$11,000 | -$6,700 | -$4,800 |
| Net Acquisitions | $0 | -$2,200 | -$2,400 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$24,500 | $0 | $0 | -$2,800 |
| Investing Cash Flow | -$31,500 | -$13,200 | -$9,100 | -$7,600 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,300 | -$2,400 | -$27,300 | -$27,300 |
| Stock Issued | $300 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$800 | -$2,200 | -$100 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $400 | $0 |
| Financing Cash Flow | -$2,000 | -$3,200 | -$29,100 | -$27,400 |
| Forex Effect | -$300 | $2,900 | $1,800 | -$4,200 |
| Net Chg. in Cash | -$19,800 | -$6,700 | -$10,700 | $18,700 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $90,300 | $97,000 | $107,700 | $89,000 |
| End Cash | $70,500 | $90,300 | $97,000 | $107,700 |
| Free Cash Flow | $7,000 | -$4,200 | $19,000 | $53,100 |